People who inherit two copies of a gene variant called APOE4 have a 60% chance of developing Alzheimer’s by age 85.
Only about 2% to 3% of people in the U.S. have this genetic profile, and most of them don’t know it because they’ve never sought genetic testing.
But three scientists are among those who did get tested, and learned that they are in the high-risk group. Now, each is making an effort to protect not only their own brain, but the brains of others with the genotype known as APOE4-4.
Can this nasal spray slow down Alzheimer’s? One couple is helping scientists find out
Joe Walsh is the first Alzheimer’s patient to be treated with an experimental nasal spray designed to reduce inflammation in the brain.
June: from dismay to hope
A genetic test from 23andMe gave June the bad new